Dabigza 75mg (Dabigatran Etexilate Capsule) 75mg

Dabigza 75mg capsules contain dabigatran etexilate, a blood thinner used to reduce clot risk. This anticoagulant helps prevent strokes and blood clots in specific conditions. Store at room temperature away from moisture. Always follow healthcare provider guidance.

Strength

75mg

Pack Size

100s

Storage

Ambient

Manufacturer / TM Owner

Glenmark Pharmaceuticals Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dabigatran etexilate is commonly prescribed to lower the risk of blood clots and stroke in people with certain heart conditions. It may also be used after knee or hip replacement surgery to prevent clots. This medication works by blocking clotting proteins in the blood. Patients often ask, 'what is dabigatran etexilate used for' to understand its role in clot prevention.

Side Effects

Dabigatran etexilate helps maintain smooth blood flow by reducing the formation of dangerous clots. Some users may notice easier circulation or reduced swelling in legs. It does not dissolve existing clots but helps prevent new ones from forming. Effects vary by individual and medical condition.

Precautions & Warnings

Keep dabigatran etexilate capsules in their original container to protect from moisture. Avoid cutting, crushing, or opening capsules unless directed. Store at room temperature and keep out of reach of children. Report any unusual bleeding or bruising to a healthcare professional promptly.

Avoid Interactions

Dabigatran etexilate may interact with other blood thinners, NSAIDs, or certain antibiotics. Alcohol and herbal supplements like ginkgo can increase bleeding risk. Always inform your doctor about all medications and supplements you take. Some interactions may require dose adjustments or monitoring.

Frequently Asked Questions

It is used to reduce the risk of blood clots and stroke in people with certain heart conditions or after specific surgeries.

Store in the original container at room temperature, away from moisture and direct light.

Avoid NSAIDs like ibuprofen unless approved by your doctor due to increased bleeding risk.

Take it as soon as you remember, but skip it if it’s almost time for the next dose; do not double up.

Consult your healthcare provider before use, as it may not be recommended during pregnancy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.